Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | FABP3 | P05413 | 9/20 | 0.44 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3930736 | 0.98 | CA1 (0.46) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL1121644 | 0.98 | CA1 (0.46) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL887075 | 0.98 | CA1 (0.46) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL5435754 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL21384974 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL23174700 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL11011436 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Silver SCHEMBL21899896 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL640842 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL22439765 | 0.95 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637569-B2 | Crosslinkable silicone elastomer composition containing a heat-resistant additive | ELKEM SILICONES FRANCE SAS (FR) | 2026-05-26 | — | — | US | claimed |
| US-20230295428-A1 | CROSSLINKABLE SILICONE ELASTOMER COMPOSITION CONTAINING A HEAT-RESISTANT ADDITIVE | ELKEM SILICONES FRANCE SAS (FR) | 2023-09-21 | — | — | US | claimed |
| EP-4189013-A1 | CROSSLINKABLE SILICONE ELASTOMER COMPOSITION CONTAINING A HEAT-RESISTANT ADDITIVE | Elkem Silicones France SAS (FR) | 2023-06-07 | — | — | EP | claimed |
| US-12637569-B2 | Crosslinkable silicone elastomer composition containing a heat-resistant additive | ELKEM SILICONES FRANCE SAS (FR) | 2026-05-26 | — | — | US | disclosed |
| US-20230295428-A1 | CROSSLINKABLE SILICONE ELASTOMER COMPOSITION CONTAINING A HEAT-RESISTANT ADDITIVE | ELKEM SILICONES FRANCE SAS (FR) | 2023-09-21 | — | — | US | disclosed |
| EP-4189013-A1 | CROSSLINKABLE SILICONE ELASTOMER COMPOSITION CONTAINING A HEAT-RESISTANT ADDITIVE | Elkem Silicones France SAS (FR) | 2023-06-07 | — | — | EP | disclosed |
| CN-116235257-A | Crosslinkable silicone elastomer composition comprising heat-resistant additive | 埃肯有机硅法国简易股份公司 | 2023-06-06 | — | — | CN | disclosed |
| US-4599201-A | OXIDATION OF CEROUS CARBVOXYLATE WITH AQUEOUS HYDROGEN PEROXIDE | RHONE-POULENC, INC. (US) | 1986-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637569-B2 | Crosslinkable silicone elastomer composition containing a heat-resistant additive | PIEZO1, COL2A1, EIF2B4 | CA1 1445/4885FABP3 4845/4885FFAR3 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.